Corrigendum to: 'An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum' and articles listed below
- PMID: 36799255
- PMCID: PMC10117608
- DOI: 10.1002/ejhf.2790
Corrigendum to: 'An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum' and articles listed below
Erratum for
-
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.Eur J Heart Fail. 2022 Jan;24(1):143-168. doi: 10.1002/ejhf.2351. Eur J Heart Fail. 2022. PMID: 35083829 Review.
-
Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry.Eur J Heart Fail. 2022 May;24(5):871-884. doi: 10.1002/ejhf.2477. Epub 2022 Mar 23. Eur J Heart Fail. 2022. PMID: 35257446 Free PMC article.
-
Impact of the COVID-19 pandemic on prescription of sacubitril/valsartan in Italy.Eur J Heart Fail. 2022 May;24(5):855-860. doi: 10.1002/ejhf.2490. Epub 2022 Mar 31. Eur J Heart Fail. 2022. PMID: 35303393 Free PMC article.
-
Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency.Eur J Heart Fail. 2022 May;24(5):833-842. doi: 10.1002/ejhf.2491. Epub 2022 Apr 21. Eur J Heart Fail. 2022. PMID: 35334136 Free PMC article.
-
Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines.Eur J Heart Fail. 2022 Jun;24(6):916-926. doi: 10.1002/ejhf.2542. Epub 2022 May 29. Eur J Heart Fail. 2022. PMID: 35579428 Review.
-
Side effects and treatment initiation barriers of sodium-glucose cotransporter 2 inhibitors in heart failure: a systematic review and meta-analysis.Eur J Heart Fail. 2022 Sep;24(9):1625-1632. doi: 10.1002/ejhf.2584. Epub 2022 Jul 8. Eur J Heart Fail. 2022. PMID: 35730422
-
An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum.Eur J Heart Fail. 2022 Sep;24(9):1467-1477. doi: 10.1002/ejhf.2612. Epub 2022 Aug 4. Eur J Heart Fail. 2022. PMID: 35791065 Free PMC article.
-
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial.Eur J Heart Fail. 2022 Oct;24(10):1928-1939. doi: 10.1002/ejhf.2630. Epub 2022 Sep 23. Eur J Heart Fail. 2022. PMID: 35869741 Free PMC article.
-
Trajectories in New York Heart Association functional class in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure Registry.Eur J Heart Fail. 2022 Nov;24(11):2093-2104. doi: 10.1002/ejhf.2644. Epub 2022 Aug 23. Eur J Heart Fail. 2022. PMID: 35999668 Free PMC article.
-
The strategic vision of the 2022-2024 mandate - greater involvement of members, young specialists for an HFA community without borders.Eur J Heart Fail. 2022 Sep;24(9):1458-1459. doi: 10.1002/ejhf.2702. Eur J Heart Fail. 2022. PMID: 36210180 No abstract available.
-
Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum.Eur J Heart Fail. 2022 Nov;24(11):2029-2036. doi: 10.1002/ejhf.2720. Epub 2022 Nov 16. Eur J Heart Fail. 2022. PMID: 36250238 Review.
References
-
- Bayés‐Genís A, Aimo A, Metra M, Anker S, Seferovic P, Rapezzi C, et al. Head‐to‐head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines. Eur J Heart Fail. 2022;24:916–26. - PubMed
-
- Metra M, Jankowska EA, Pagnesi M, Anker SD, Butler J, Dorigotti F, et al.; AFFIRM‐AHF Investigators . Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial. Eur J Heart Fail. 2022;24:1928–39. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources